Neimeth International Pharmaceuticals Plc reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was NGN 553.22 million compared to NGN 875.99 million a year ago. Net loss was NGN 119.6 million compared to net income of NGN 23.99 million a year ago. Basic loss per share from continuing operations was NGN 3 compared to basic earnings per share from continuing operations of NGN 1 a year ago.
For the nine months, sales was NGN 1,510.63 million compared to NGN 2,510.74 million a year ago. Net loss was NGN 572.16 million compared to net income of NGN 199.45 million a year ago. Basic loss per share from continuing operations was NGN 13 compared to basic earnings per share from continuing operations of NGN 11 a year ago.